Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Intake of vitamins D and A and calcium and risk of non-Hodgkin lymphoma: San Francisco Bay Area population-based case-control study.

Mikhak B, Bracci PM, Gong Z.

Nutr Cancer. 2012;64(5):674-84. doi: 10.1080/01635581.2012.689916. Epub 2012 Jun 14.

2.

Angiopoietin-like 4 (ANGPTL4) gene polymorphisms and risk of brain arteriovenous malformations.

Mikhak B, Weinsheimer S, Pawlikowska L, Poon A, Kwok PY, Lawton MT, Chen Y, Zaroff JG, Sidney S, McCulloch CE, Young WL, Kim H.

Cerebrovasc Dis. 2011;31(4):338-45. doi: 10.1159/000322601. Epub 2011 Jan 7.

3.

A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery.

Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL.

Neurosurgery. 2010 Apr;66(4):702-13; discussion 713. doi: 10.1227/01.NEU.0000367555.16733.E1.

4.

Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk.

Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Wu K, Erdman JW Jr, Giovannucci E.

Carcinogenesis. 2008 Dec;29(12):2335-40. doi: 10.1093/carcin/bgn212. Epub 2008 Sep 10.

5.

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.

Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E.

Prostate. 2007 Jun 15;67(9):911-23.

PMID:
17440943
6.

Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.

Simons JW, Carducci MA, Mikhak B, Lim M, Biedrzycki B, Borellini F, Clift SM, Hege KM, Ando DG, Piantadosi S, Mulligan R, Nelson WG.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3394-401.

7.

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

DeWeese TL, van der Poel H, Li S, Mikhak B, Drew R, Goemann M, Hamper U, DeJong R, Detorie N, Rodriguez R, Haulk T, DeMarzo AM, Piantadosi S, Yu DC, Chen Y, Henderson DR, Carducci MA, Nelson WG, Simons JW.

Cancer Res. 2001 Oct 15;61(20):7464-72.

8.

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.

Nelson WG, Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Kim M, Weber CE, Baccala AA, Goeman MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF.

Cancer Chemother Pharmacol. 2000;46 Suppl:S67-72.

PMID:
10950151
9.

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Lim M, Weber CE, Baccala AA, Goemann MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF, Nelson WG.

Cancer Res. 1999 Oct 15;59(20):5160-8.

10.

Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.

Mikhak B, Zahurak M, Abeloff MD, Fetting JH, Davidson NE, Donehower RC, Waterfield W, Kennedy MJ.

Cancer. 1999 Feb 15;85(4):899-904.

PMID:
10091768
11.

Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology.

Simons JW, Mikhak B.

Semin Oncol. 1998 Dec;25(6):661-76. Review.

PMID:
9865681
12.

Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.

de la Rosa A, Mikhak B, Steeg PS.

Arch Med Res. 1996 Autumn;27(3):395-401.

PMID:
8854401

Supplemental Content

Loading ...
Support Center